| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −15.1× | −1.7× | |
| Price / Book | 1.4× | 2.0× | |
| Price / Sales | 1.6× | 4.0× | |
| Price / Free cash flow | −11.9× | −1.5× | |
| EV / EBITDA | 99.0× | −1.2× | |
| Earnings yield | −6.6% | −14.4% | |
| Free cash flow yield | −8.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,302.01 | +4.97% | $1.23T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $260.21 | +2.53% | $627.08B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.84 | +2.18% | $510.41B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $415.38 | +2.09% | $372.84B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $149.07 | +3.79% | $367.78B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.11 | +1.94% | $282.26B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.16 | +2.57% | $260.8B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $682.65 | +0.48% | $252.41B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.28 | +2.20% | $234.79B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.86 | +2.47% | $194.49B | 22.3× | 37.5% | +29.9% |
